Company
AbbVie Inc. (ABBV)
Standardized SEC financial data for AbbVie Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001551152 · NYSE · Pharmaceutical Preparations.
Gross margin
70.2%
Operating margin
24.6%
Net margin
6.8%
Revenue growth (YoY)
8.6%
Return on equity
-128.0%
ROIC
15.6%
Free cash flow
$17.82B
Debt / equity
-21.58×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $45.80B | $56.20B | $58.05B | $54.32B | $56.33B | $61.16B |
| Cost of revenue |
Balance sheet
| USD | FY2023 | FY2023 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | $12.81B | $5.52B | $5.23B |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $17.59B | $22.78B | $24.94B | $22.84B | $18.81B | $19.03B |
| Capital expenditures |
Get ABBV data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ABBV/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ABBV/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"